Drugs / Danzhu Fuyuan Granule
last change Dec 2021 re-read 3 minutes ago

Danzhu Fuyuan Granule

Developed for
idiopathic membranous glomerulonephritis · intermediate coronary syndrome · vascular dementia
Investigated by
Jingqing Hu

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT04498962 Aug 2020 → Jun 2021 idiopathic membranous glomerulonephritis, intermediate coronary syndrome, vascular dementia Jingqing Hu Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Danzhu Fuyuan Granule ClinicalTrials.gov intervention name — accepted as the source's own label NCT04498962 ↗